Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
Autor: | Anand Rajan, Katherine N. Gibson-Corley, Georgina K. Ofori-Amanfo, Patrick Ten Eyck, Allen B. Choi, Steven M. Sperry, Andrean L. Simons, Madelyn Espinosa-Cotton |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Article Subject medicine.medical_treatment Cell Perineural invasion Alpha (ethology) lcsh:RC254-282 03 medical and health sciences 0302 clinical medicine Medicine Epidermal growth factor receptor Tissue microarray biology business.industry Interleukin lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens 030104 developmental biology medicine.anatomical_structure Cytokine Oncology 030220 oncology & carcinogenesis Cancer research biology.protein Immunohistochemistry business Research Article |
Zdroj: | Journal of Oncology, Vol 2019 (2019) Journal of Oncology |
ISSN: | 1687-8469 1687-8450 |
Popis: | Interleukin-1 alpha (IL-1α) is a pleiotropic cytokine involved in inflammation and immune response and is upregulated in many solid tumors including head and neck squamous cell carcinomas. Although IL-1αexpression is generally associated with poor prognosis, the implications of the subcellular localization of IL-1αexpression in patient outcomes are poorly understood. This study is aimed at investigating the prognostic value of nuclear and cytoplasmic immunohistochemical IL-1αexpression in oral squamous cell carcinomas (OSCCs). Tissue microarrays containing 146 OSCCs were analyzed for IL-1αand epidermal growth factor receptor (EGFR) expression by immunohistochemistry. IL-1αand EGFR expression scores were correlated with clinicopathological parameters and survival outcomes. IL-1αexpression was observed in the nuclear and/or cytoplasmic compartments in 98% of evaluable tumors and 78% of tumors expressed IL-1αin both compartments. There were no differences observed in overall survival or progression-free survival between high, moderate, or negative IL-1αnuclear/cytoplasmic expression scores. When IL-1αnuclear/cytoplasmic expression scores were stratified by positive or negative EGFR expression, tumors with a combined EGFR-positive and high nuclear IL-1αexpression profile were significantly more likely to possess perineural invasion and were significantly associated with a high risk of tumor recurrence and worse progression-free survival compared to all other EGFR and combined IL-1α/EGFR expression profiles. Altogether, nuclear IL-1αexpression may enhance the prognostic value of EGFR in OSCC and warrants further study as a prognostic biomarker for recurrence. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |